Impact, mechanisms, and novel chemotherapy strategies for overcoming resistance to anthracyclines and taxanes in metastatic breast cancer Edith A. Perez Review 29 April 2008 Pages: 195 - 201
Programmed Cell Death 4 inhibits breast cancer cell invasion by increasing Tissue Inhibitor of Metalloproteinases-2 expression René Nieves-AliceaNancy H. ColburnAna M. Tari Preclinical Study 04 April 2008 Pages: 203 - 209
Src inhibitors in early breast cancer: a methodology, feasibility and variability study R. J. JonesO. YoungJ. M. Dixon Preclinical Study 14 April 2008 Pages: 211 - 221
Detection of human mammaglobin mRNA in serial peripheral blood samples from patients with non-metastatic breast cancer is not predictive of disease recurrence Ana Rita MarquesElsa TeixeiraJosé Luís Passos-Coelho Preclinical Study 13 April 2008 Pages: 223 - 232
Transcriptional profiles of progestogen effects in the postmenopausal breast Charles E. WoodThomas C. RegisterJ. Mark Cline Preclinical Study 11 April 2008 Pages: 233 - 242
The biological and clinical characteristics of breast carcinoma with mixed ductal and lobular morphology Emad A. RakhaMuhammad S. GillIan O. Ellis Preclinical Study 11 April 2008 Pages: 243 - 250
RETRACTED ARTICLE: Glypican-3 regulates migration, adhesion and actin cytoskeleton organization in mammary tumor cells through Wnt signaling modulation Ivan StiglianoLydia PuricelliMaría Giselle Peters Preclinical Study 11 April 2008 Pages: 251 - 262
Activation of ErbB3, EGFR and Erk is essential for growth of human breast cancer cell lines with acquired resistance to fulvestrant Thomas FrogneRikke V. BenjaminsenAnne E. Lykkesfeldt Preclinical study 14 April 2008 Pages: 263 - 275
Detection and downregulation of type I IGF receptor expression by antibody-conjugated quantum dots in breast cancer cells Hua ZhangDeepali SachdevDouglas Yee Preclinical Study 17 April 2008 Pages: 277 - 285
Molecular profiles of progesterone receptor loss in human breast tumors Chad J. CreightonC. Kent OsborneRachel Schiff Preclinical Study 19 April 2008 Pages: 287 - 299
Axillary recurrence after negative sentinel lymph node biopsy Hee Jeong KimByung Ho SonSei Hyun Ahn Clinical Trial 04 April 2008 Pages: 301 - 305
Pulsed reduced dose-rate radiotherapy: a novel locoregional retreatment strategy for breast cancer recurrence in the previously irradiated chest wall, axilla, or supraclavicular region Gregory M. RichardsWolfgang A. ToméSteven P. Howard Clinical Trial 04 April 2008 Pages: 307 - 313
Promoter hypermethylation in sentinel lymph nodes as a marker for breast cancer recurrence Hetty E. CarrawayShelun WangJulie R. Lange Clinical Trial 11 April 2008 Pages: 315 - 325
Association of genetic polymorphisms of ER-α and the estradiol-synthesizing enzyme genes CYP17 and CYP19 with breast cancer risk in Chinese women Lina ZhangLin GuKexin Chen Epidemiology 16 July 2008 Pages: 327 - 338
Breast cancer characteristics at diagnosis and survival among Arab–American women compared to European– and African–American women Sharon Hensley AlfordKendra SchwartzSofia D. Merajver Epidemiology 15 April 2008 Pages: 339 - 346
Association of single nucleotide polymorphisms (SNPs) in TNF-LTA locus with breast cancer risk in Indian population Indu KohaarPratibha TiwariMausumi Bharadwaj Epidemiology 14 April 2008 Pages: 347 - 355
Changes in quality of life among breast cancer patients three years post-diagnosis Wei LuYong CuiXiao-Ou Shu Epidemiology 14 April 2008 Pages: 357 - 369
HER2 codon 655 polymorphism and breast cancer risk: a meta-analysis Weiyang TaoChunyang WangHongchi Jiang Epidemiology 26 April 2008 Pages: 371 - 376
Effect of Coenzyme Q10, Riboflavin and Niacin on Tamoxifen treated postmenopausal breast cancer women with special reference to blood chemistry profiles Srinivasan YuvarajVummidi Gridhar PremkumarPanchanatham Sachdanandam Brief Report 22 April 2008 Pages: 377 - 384
Poor usage of HUGO standard gene nomenclature in breast cancer studies Marc Lacroix Letter to the Editor 10 April 2008 Pages: 385 - 386
Utility of metformin in breast cancer treatment, is neoangiogenesis a risk factor? Vuk StambolicJames R. WoodgettPamela J. Goodwin Letter to the Editor 26 April 2008 Pages: 387 - 389
Therapeutic metformin/AMPK activation promotes the angiogenic phenotype in the ERα negative MDA-MB-435 breast cancer model Sirwan M. HadadVirginia AppleyardAlastair M. Thompson Letter to the editor 18 April 2008 Pages: 391 - 391